Tirofiban hydrochloride anhydrous
- Level
- Commodity
- Parent
- 51431500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51431508This classification denotes an antiplatelet agent with the molecular formula C22H36N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IKE1P4X57J, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, hydrochloride (1:1), but more generally known as tirofiban hydrochloride anhydrous, which bears US NIH Compound Identifier 64781. European Medicines Agency schedules tirofiban hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11118MIG. Most nations, for tariff purposes, schedule tirofiban hydrochloride anhydrous under HS 29350090. SMILES: CCCCS(=O)(=O)N[C@@H](CC1CCC(CC1)OCCCCC2CCNCC2)C(=O)O.CL.
Same parent
Under 51431500 · 10Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.